PRTA Cash-Secured Put Strategy

PRTA (Prothena Corporation plc), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Prothena Corporation plc, a late-stage clinical biotechnology company, focuses on discovery and development of novel therapies to treat diseases caused by protein dysregulation. Its product pipeline includes Prasinezumab, an investigational humanized monoclonal antibody which is in Phase 3 clinical trial for the treatment of parkinson’s disease and other synucleinopathies. The company also develops Coramitug, an investigational antibody, which is in Phase 3 clinical trial for the treatment of transthyretin amyloidosis; BMS-986446, an anti-tau antibody which is in Phase 2 clinical trial to treat Alzheimer’s disease; PRX019, an investigational antibody which is in Phase 1 clinical trial for the treatment of neurodegenerative diseases; and PRX123, a Dual Aß-Tau Vaccine, which is in preclinical trial for treating Alzheimer’s disease. In addition, it develops discovery- and late-preclinical-stage programs include TDP-43 CYTOPE for the treatment of amyotrophic lateral sclerosis; PRX012, a next-generation anti-Aß antibody which is in phase 1 clinical trial to treat Alzheimer’s disease; and PRX012-TfR, a preclinical program for the treatment of Alzheimer’s disease. It has a license, development, and commercialization agreement with F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. to develop and commercialize antibodies that target a-synuclein, including prasinezumab; and master collaboration agreement with Bristol Myers Squibb to develop and commercialize antibodies targeting tau, TDP-43.

PRTA (Prothena Corporation plc) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $524.6M, a beta of -0.32 versus the broader market, a 52-week range of 5.96-11.8, average daily share volume of 541K, a public-listing history dating back to 2012, approximately 67 full-time employees. These structural characteristics shape how PRTA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of -0.32 indicates PRTA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a cash-secured put on PRTA?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

Current PRTA snapshot

As of June 30, 2026, spot at $9.89, ATM IV 68.90%, IV rank 11.41%, expected move 19.75%. The cash-secured put on PRTA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this cash-secured put structure on PRTA specifically: PRTA IV at 68.90% is on the cheap side of its 1-year range, which means a premium-selling PRTA cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 19.75% (roughly $1.95 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PRTA expiries trade a higher absolute premium for lower per-day decay. Position sizing on PRTA should anchor to the underlying notional of $9.89 per share and to the trader's directional view on PRTA stock.

PRTA cash-secured put setup

The PRTA cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PRTA near $9.89, the first option leg uses a $9.40 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PRTA chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PRTA shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Sell 1Put$9.40N/A

PRTA cash-secured put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

PRTA cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on PRTA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use cash-secured put on PRTA

Cash-secured puts on PRTA earn premium while a trader waits to acquire PRTA stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning PRTA.

PRTA thesis for this cash-secured put

The market-implied 1-standard-deviation range for PRTA extends from approximately $7.94 on the downside to $11.84 on the upside. A PRTA cash-secured put lets a trader earn premium while waiting to acquire PRTA at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current PRTA IV rank near 11.41% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PRTA at 68.90%. As a Healthcare name, PRTA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PRTA-specific events.

PRTA cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PRTA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PRTA alongside the broader basket even when PRTA-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on PRTA carry tail risk when realized volatility exceeds the implied move; review historical PRTA earnings reactions and macro stress periods before sizing. Always rebuild the position from current PRTA chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on PRTA?
A cash-secured put on PRTA is the cash-secured put strategy applied to PRTA (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With PRTA stock trading near $9.89, the strikes shown on this page are snapped to the nearest listed PRTA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are PRTA cash-secured put max profit and max loss calculated?
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the PRTA cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 68.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a PRTA cash-secured put?
The breakeven for the PRTA cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PRTA market-implied 1-standard-deviation expected move is approximately 19.75%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on PRTA?
Cash-secured puts on PRTA earn premium while a trader waits to acquire PRTA stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning PRTA.
How does current PRTA implied volatility affect this cash-secured put?
PRTA ATM IV is at 68.90% with IV rank near 11.41%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related PRTA analysis